Malignant bowel obstruction: tailoring treatment to individual patients.
Ripamonti
Carla Ida
CI
Palliative Care Unit, IRCCS Foundation, National Cancer Institute of Milan, Via Venezian 1, 1-20133 Milan, Italy. carla.ripamonti@istitutotumori.mi.it
D000008:Abdominal Neoplasms / Q000150:complications* / Q000523:psychology; D000223:Adaptation, Psychological; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000150:complications* / Q000523:psychology / Q000556:secondary; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology* / Q000523:psychology / Q000628:therapy*; D015282:Octreotide / Q000627:therapeutic use; D010347:Patient Care Planning; D018570:Risk Assessment
D000970:Antineoplastic Agents; D015282:Octreotide